Is a methodology available that accurately measures the cost of an FDG-PET study?
Krug
Bruno
B
Nuclear Medicine Department, Université Catholique de Louvain, 1 Dr Thérasse, 5530, Yvoir, Belgium. bruno.krug@imre.ucl.ac.be.
Pirson
Anne Sophie
AS
Nuclear Medicine Department, Université Catholique de Louvain, 1 Dr Thérasse, 5530, Yvoir, Belgium.
Crott
Ralph
R
Belgian Health Care Knowledge Center, Brussels, Belgium.
Vander Borght
Thierry
T
Nuclear Medicine Department, Université Catholique de Louvain, 1 Dr Thérasse, 5530, Yvoir, Belgium.
D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D003952:Diagnostic Imaging / Q000191:economics; D004470:Economics, Medical; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography / Q000191:economics* / Q000379:methods*; D019275:Radiopharmaceuticals
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18